RhumbLine Advisers’s Aehr Test Systems AEHR Stock Holding History

RhumbLine Advisers’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.73M	Buy	38,835 +2,002	+5%	+$183K	﹤0.01%	1612
2026 Q1	$1.37M	Buy	36,833 +695	+2%	+$22.2K	﹤0.01%	2040
2025 Q4	$730K	Sell	36,138 -4,479	-11%	-$108K	﹤0.01%	2412
2025 Q3	$1.22M	Sell	40,617 -849	-2%	-$18.4K	﹤0.01%	2141
2025 Q2	$536K	Buy	41,466 +1,254	+3%	+$11.9K	﹤0.01%	2647
2025 Q1	$293K	Buy	40,212 +2,165	+6%	+$23.9K	﹤0.01%	2899
2024 Q4	$633K	Buy	38,047 +303	+0.8%	+$4.04K	﹤0.01%	2520
2024 Q3	$485K	Sell	37,744 -1,589	-4%	-$23K	﹤0.01%	2718
2024 Q2	$439K	Buy	39,333 +1,438	+4%	+$16.8K	﹤0.01%	2772
2024 Q1	$470K	Sell	37,895 -576	-1%	-$9.6K	﹤0.01%	2698
2023 Q4	$1.02M	Buy	38,471 +504	+1%	+$14.7K	﹤0.01%	2236
2023 Q3	$1.74M	Buy	37,967 +736	+2%	+$34.1K	﹤0.01%	1925
2023 Q2	$1.54M	Buy	+37,231	New	+$1.22M	﹤0.01%	2054

Other funds holding AEHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

RhumbLine Advisers's AEHR Position: Q2 2026 in Review

RhumbLine Advisers increased its Aehr Test Systems (AEHR) stake by 5.4% in Q2 2026, buying an estimated $183K and bringing the position to 38,835 shares worth $3.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1612.

RhumbLine Advisers first reported a position in AEHR in Q2 2023 and has held it in 13 quarters since. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

RhumbLine Advisers held 38,835 shares of Aehr Test Systems worth $3.73M as of Q2 2026.
RhumbLine Advisers bought 2,002 Aehr Test Systems shares in Q2 2026, an estimated $183K.
Aehr Test Systems made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1612 holding.
RhumbLine Advisers first reported a position in Aehr Test Systems in Q2 2023 and has held it in 13 quarters since.
262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.